Search

Envista Holdings Corp

Fechado

SetorSaúde

26.41 1.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

26.39

Máximo

26.62

Indicadores-chave

By Trading Economics

Rendimento

5.8M

39M

Vendas

-45M

706M

P/E

Médio do Setor

64.829

62.58

EPS

0.36

Margem de lucro

5.485

Funcionários

12,000

EBITDA

-22M

83M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+13.52% upside

Dividendos

By Acuity

Próximos Ganhos

5 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

119M

4.3B

Abertura anterior

25.14

Fecho anterior

26.41

Sentimento de Notícias

By Acuity

50%

50%

152 / 340 Ranking em Healthcare

Envista Holdings Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de jul. de 2026, 19:27 UTC

Envista Holdings Corp is trading higher, benefiting from strength in the Health Care Equipment sub-sector. The stock peaked earlier in the session before a slight retracement.

20 de jul. de 2026, 18:56 UTC

Envista Holdings Corp is lower today, continuing a decline since Friday's close. Broader market pressures include rising US Treasury yields amid inflation concerns.

Comparação entre Pares

Variação de preço

Envista Holdings Corp Previsão

Preço-alvo

By TipRanks

13.52% parte superior

Previsão para 12 meses

Média 29.89 USD  13.52%

Máximo 34 USD

Mínimo 25 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para Envista Holdings Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

11 ratings

6

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

152 / 340 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
help-icon Live chat